Pseudo-modified Uridine Triphosphate: Redefining mRNA Syn...

2025-09-25

Explore how Pseudo-modified uridine triphosphate (Pseudo-UTP) revolutionizes mRNA synthesis with pseudouridine modification, enabling next-generation vaccine development and RNA therapeutics. Discover unique insights into OMV-based delivery and future directions for personalized medicine.

Adenosine Triphosphate (ATP): Decoding Post-Translational...

2025-09-24

Explore the evolving landscape of Adenosine Triphosphate (ATP) in mitochondrial metabolism, focusing on its pivotal role in post-translational enzyme regulation and metabolic pathway investigation. This cornerstone article synthesizes new research insights, offering an advanced perspective beyond traditional views of ATP as a universal energy carrier.

Gastrin I (human): Advancing Intestinal Organoid and CCK2...

2025-09-23

Explore the pivotal role of Gastrin I (human) as a gastric acid secretion regulator and CCK2 receptor agonist in next-generation gastrointestinal physiology studies, with a focus on its applications in intestinal organoid models and receptor-mediated signal transduction.

L1023 Anti-Cancer Compound Library: Empowering Target Dis...

2025-09-22

Explore how the L1023 Anti-Cancer Compound Library accelerates drug discovery for clear cell renal cell carcinoma (ccRCC) and other malignancies by enabling high-throughput screening of potent, cell-permeable anti-cancer agents targeting critical pathways such as BRAF kinase, EZH2, and mTOR.

eukaryotic translation initiation factor 3

2025-09-19

Plerixafor (AMD3100) in Translational Research: Mechanism...

2025-09-19

Explore the multifaceted research applications of Plerixafor (AMD3100), a potent CXCR4 chemokine receptor antagonist, with a focus on its mechanistic role in hematopoietic stem cell and neutrophil mobilization, cancer metastasis inhibition, and emerging directions beyond oncology.

Anti-mTOR Rabbit Polyclonal Antibody

2025-09-19

WY-14643 (Pirinixic Acid): A Selective PPARα Agonist Shap...

2025-09-18

This article examines WY-14643 (Pirinixic Acid) as a potent and selective PPARα agonist, highlighting its applications in metabolic disorder research and its roles in lipid metabolism regulation and TNF-α mediated inflammation. Recent findings in cancer biology and inflammation are contextualized to inform experimental design and mechanistic studies.

GSK963

2025-09-18

Cefotetan

2025-09-18

GNE-064

2025-09-17

Anti-GRP78 BiP Rabbit Polyclonal Antibody

2025-09-17

ANP (1-11), rat

2025-09-16

BT173

2025-09-16

Dienestrol

2025-09-15